全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Estimation and Assessment of D-Dimer Levels in Sudanese Patients with Pulmonary Tuberculosis

DOI: 10.4236/oalib.1103211, PP. 1-6

Subject Areas: Hematology

Keywords: D-Dimer, Mycobacterium tuberculosis, TB, Sudan

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: The association between pulmonary tuberculosis and a hypercoagulable state is well documented. An increased D-dimer level is linked with increasing the mortality of pulmonary tuberculosis infection. Objective: The current study aimed to the estimation and assessment of the D-dimer levels in Sudanese patients with pulmonary tuberculosis. Material and Methods: This is a case control study that was conducted during March 2016 at Faculty of Medical Laboratory Sciences, Alneelain University, Khartoum, Sudan. A total of 70 subjects were included in this study, classified into two groups. The first group consists of 40 subjects, among which 30 (75%) were males and 10 (25%) were female; their mean age is 32.3 years classified as patients group; of other 30 normal healthy subjects, 15 (50%) were female and 15 (50%) were males; their mean age was 33.1 years in the second group as normal control group. The platelet poor plasma was prepared immediately from citrated blood by centrifuging at 2000 rpm for 15 minutes. The data were collected by structured interview and questionnaire, and then analyzed by using a computer program statistical package for social sciences (SPSS) version 21. The D-dimer levels were measured using immunometric assay (Nyco Card READER II). Result: The present study found that the D-dimer levels were statistically significantly higher in pulmonary tuberculosis patients compared to the normal healthy control groups (Mean ± SD 0.82 ± 0.54 vs. 0.33 ± 0.13 with p value 0.00). Conclusion: This study showed that Sudanese patient with pulmonary tuberculosis has increased the plasma D-dimer level, and this abnormality could be prone to Deep Vein Thrombosis (DVT).

Cite this paper

Alhassan, S. A. A. and Gaufri, N. E. A. M. (2017). Estimation and Assessment of D-Dimer Levels in Sudanese Patients with Pulmonary Tuberculosis. Open Access Library Journal, 4, e3211. doi: http://dx.doi.org/10.4236/oalib.1103211.

References

[1]  Ryan, K.J. and Ray, C.G. (2004) “Mycobacteria”. Sherris Medical Microbiology: An Introduction to Infectious Diseases. 4th Edition, McGraw-Hill, New York, 439.
[2]  Bregani, E.R., Valcarenghi, C., Van Tien, T. and Monzani, V. (2013) Suggestive Criteria for Pulmonary Tuberculosis in Developing Countries. International Journal of Mycobacteriology, 2, 211-213.
[3]  Fraser, R.S. (1992) Pulmonary Aspergillosis: Pathologic and Pathogenetic Features. Patholoannual, 28, 231-277.
[4]  Malani, P.N. (2010) Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. JAMA, 304, 2067-2071.
https://doi.org/10.1001/jama.2010.1643
[5]  Organization, W.H. (2011) Global Tuberculosis Control: WHO Report 2010. World Health Organization.
[6]  Organization, W.H. (2010) Global Tuberculosis Control: WHO Report 2010. World Health Organization.
[7]  Kielstra, P. (2014) Ancient Enemy, Modern Imperative. A Time for Greater Action against Tuberculosis. The Economist.
[8]  El Fekih, L., Oueslati, I., Hassene, H., Fenniche, S., Belhabib, D. and Megdiche, M.L. (2009) Association Thromboses Veineuses Profondes avec Tuberculose Pulmonaire. Tunis Med, 87, 328-329.
[9]  Adam, S.S., Key, N.S. and Greenberg, C.S. (2009) D-Dimer Antigen: Current Concepts and Future Prospects. Blood, 113, 2878-2887.
https://doi.org/10.1182/blood-2008-06-165845
[10]  Petersen, K. (2010) Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. In: Mandell, G.L., Bennett, J.E. and Dolin, R., Eds., Vol. 51, Churchill Livingstone Elsevier, Philadelphia, 636-637.
[11]  Philip-Joet, F., Alessi, M.C., Philip-Joet, C., Aillaud, M., Barriere, J.R., Arnaud, A. and Juhan-Vague, I. (1995) Fibrinolytic and Inflammatory Processes in Pleural Effusions. European Respiratory Journal, 8, 1352-1356.
[12]  Eldin, G.S.S., Fadl-Elmula, I., Ali, M.S., Ali, A.B., Salih, A.L.G., Mallard, K., Bottomley, C. and Mcnerney, R. (2011) Tuberculosis in Sudan: A Study of Mycobacterium tuberculosis Strain Genotype and Susceptibility to Anti-Tuberculosis Drugs. BMC Infectious Diseases, 11, 1.
[13]  Robson, S.C., White, N.W., Aronson, I., Woollgar, R., Goodman, H. and Jacobs, P. (1996) Acute-Phase Response and the Hypercoagulable State in Pulmonary Tuberculosis. British Journal of Haematology, 93, 943-949.
https://doi.org/10.1046/j.1365-2141.1996.d01-1722.x
[14]  Shen, Y., Yang, T., Jia, L., Wang, T., Chen, L., Wan, C., Wang, L., Yan, Y. and Yi, Q. (2013) A Potential Role for D-Dimer in the Diagnosis of Tuberculous Pleural Effusion. Age, 52, 15.
[15]  Zahn, D.W. and Peirce, C.T. (1948) Venous Thrombosis and Pulmonary Embolism in Tuberculosis. The American Journal of Medicine, 5, 716-728.
https://doi.org/10.1016/0002-9343(48)90149-1
[16]  Gupta, D., Gupta, S., Balamugesh, T., Aggarwal, A.N. and Das, R. (2005) Circulating D-Dimers as a Marker of Disease Activity in Pulmonary Sarcoidosis. Indian Journal of Chest Diseases and Allied Sciences, 47, 175.
[17]  Christ-Crain, M., Morgenthaler, N.G., Stolz, D., Müller, C., Bingisser, R., Harbarth, S., Tamm, M., Struck, J., Bergmann, A. and Müller, B. (2006) Pro-Adrenomedullin to Predict Severity and Outcome in Community-Acquired Pneumonia. Critical Care, 10, R96.
[18]  Kager, L.M., Blok, D.C., Lede, I.O., Rahman, W., Afroz, R., Bresser, P., Van der Zee, J. S., Ghose, A., Visser, C.E. and De Jong, M.D. (2015) Pulmonary Tuberculosis Induces a Systemic Hypercoagulable State. Journal of Infection, 70, 324-334.
https://doi.org/10.1016/j.jinf.2014.10.006

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413